Biotechnology & Medical Research

(Reuters) - The upcoming New Year's Eve will mark the second anniversary of the first reported COVID-19 case in Wuhan,...

By Emilio Parodi MILAN (Reuters) - The EU drug regulator will not decide whether to approve Merck & Co's COVID-19...

TOKYO (Reuters) - Japanese Prime Minister Fumio Kishida said he had spoken with the head of Pfizer Inc on Friday...

(Reuters) - Novavax's COVID-19 vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing...

By Francesco Guarascio and Panu Wongcha-um BRUSSELS/BANGKOK (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from...

KUALA LUMPUR (Reuters) - Malaysia on Thursday announced new COVID-19 restrictions, including banning mass gatherings and requiring booster doses for...

TOKYO (Reuters) - Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed...

(Reuters) - The European Union's drug regulator on Wednesday recommended that a booster dose of Johnson & Johnson's COVID-19 shot...

By Krishna N. Das NEW DELHI (Reuters) - India is struggling to export its surplus of COVID-19 vaccines as logistical...

By Francesco Guarascio BRUSSELS (Reuters) - Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19...

By Alexander Winning and Wendell Roelf JOHANNESBURG (Reuters) - Pfizer-BioNTech's COVID-19 vaccine has been less effective in South Africa at...

By Ludwig Burger FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose...

By Heru Asprihanto JAKARTA (Reuters) - Indonesia started vaccinating elementary school children aged 6-11 against COVID-19 on Tuesday, becoming one...

ABUJA (Reuters) - Nigeria will destroy around one million expired COVID-19 vaccines, Faisal Shuaib, head of the National Primary Health...

By Colin Packham CANBERRA (Reuters) -Australia said on Sunday it will shorten the wait time for people to receive a...

SYDNEY (Reuters) - Australia will begin administering COVID-19 vaccines for children aged 5 to 11 from Jan. 10, Prime Minister...

By Ludwig Burger and Michael Erman (Reuters) -BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine...

By Julie Steenhuysen (Reuters) - Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible...

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - The German state of Saxony, among the hardest hit by surging...

By Promit Mukherjee and Trevor Hunnicutt JOHANNESBURG/WASHINGTON (Reuters) - Heavily mutated Omicron is rapidly becoming the dominant variant of the...